2 hours ago
Multiple Sclerosis Society is investing $1.5B in cannabis research for MS in partnership with the Canadian Institute for Health Research. Building the evidence base for medical cannabis therapies in Canada is a major step! @CIHR_IRSC @MSSocietyCanada https://t.co/GQM1pyU4zu
21 hours ago
THCV is a little-known cannabinoid that suppresses appetite. GreenSeal's ongoing genetic selection program includes testing cannabis strains with potential for high #THCV content. Anyone interested in consuming cannabis without getting the munchies? https://t.co/0dyGIJYlqt
Stay in the know.
Join the GreenSeal email list.